given experimental observations of such sets, we infer the underlying network connecting these entities by generating an ensemble of networks consistent with the data.
often it is impossible, or expensive, to determine the network structure by experimental validation of the binary interactions between every vertex pair.
exponential random graphs are used to generate and sample the ensemble of consistent networks, and we take an algorithmic approach to numerically execute the inference method.
the network inference method presented here can be applied to resolve different types of networks in current systems biology and systems pharmacology as well as in other fields of research.
the skeleton of complex systems can be represented as networks where vertices represent entities, and edges represent the relations between these entities.
this type of data is ubiquitous in the field of systems biology and in other areas of complex systems research.
it is usually more practical to infer the network from surrogate observations.
while many algorithms have been developed to infer networks from quantitative data, less attention has been paid to methods which infer networks from repeated co-occurrence of entities in related sets.
the effectiveness of the method is demonstrated on synthetic data before employing this inference approach to problems in systems biology and systems pharmacology, as well as to construct a co-authorship collaboration network.
network inference is the process by which an underlying network of relations between entities is determined from indirect evidence.
here we present a general method for network inference from repeated observations of sets of related entities.
we predict direct protein-protein interactions from high-throughput mass-spectrometry proteomics, integrate data from chip-seq and loss-of-function/gain-of-function followed by expression data to infer a network of associations between pluripotency regulators, extract a network that connects  <dig> cancer drugs to each other and to  <dig> severe adverse events by mining the fdaâ€™s adverse events reporting systems , and construct a co-authorship network that connects mount sinai school of medicine investigators.
